| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | EQL0E9GCX1 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Beta-nerve growth factor inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoarthritis, Hip | 3 | D015207 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Osteoarthritis, Knee | 3 | D020370 | ClinicalTrials |
| Low Back Pain | 3 | D017116 | ClinicalTrials |
| Chronic Pain | 3 | D059350 | ClinicalTrials |
| Osteoarthritis | 3 | D010003 | ClinicalTrials |
| Neuralgia, Postherpetic | 2 | D051474 | ClinicalTrials |
| Pancreatitis, Chronic | 2 | D050500 | ClinicalTrials |
| Prostatitis | 2 | D011472 | ClinicalTrials |
| Cystitis, Interstitial | 2 | D018856 | ClinicalTrials |
| Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
| Endometriosis | 2 | D004715 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 880266-57-9 |
| ChEMBL | CHEMBL2108567 |
| FDA SRS | EQL0E9GCX1 |
| Guide to Pharmacology | 8415 |
CONTENTS